Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$60.0M
total disclosed, rounds participated
Stages
—
About
VC
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Omega Funds' primary sector focus for investments?
- Omega Funds primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
- Can you name some of Omega Funds' notable portfolio companies?
- Omega Funds' portfolio includes SoniVie, which develops pulmonary hypertension denervation treatment, and Upstream Bio, focused on monoclonal antibody drugs for asthma patients.
- What was a recent exit for Omega Funds?
- In March 2025, Omega Funds had an exit with SoniVie, which was acquired by Boston Scientific for $400M.
- What is the most recent investment round Omega Funds participated in?
- Omega Funds participated in a B Round for Upstream Bio in January 2023, which raised $400M.
- What is the typical investment range for Omega Funds?
- Omega Funds typically invests in the range of $60M to $200M.
- How many investment rounds has Omega Funds participated in over the last two years?
- Omega Funds has participated in three investment rounds between June 2022 and June 2023, including a C Round, an A Round, and a B Round.